UCB Collaborates with Ailux Biologics to Revolutionize Biologics Development with AI
In an era where artificial intelligence (AI) is reshaping industries, UCB, a global biopharmaceutical leader, has teamed up with Ailux Biologics, a division of the cutting-edge AI-focused company XtalPi, to revolutionize biologics development. This collaboration leverages XtalFold™, a state-of-the-art AI platform designed to accelerate the discovery and optimization of biologics, offering unprecedented opportunities in therapeutic innovation.